Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-01

AUTHORS

Chie Yoshimura, Shosaku Nomura, Shigenori Kanazawa, Midori Kuwana, Kazuyuki Yamaguchi, Shirou Fukuhara

ABSTRACT

PURPOSE: High-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) has become an important treatment for solid tumors including lung cancer. METHODS: We measured IL-12 levels in patients with lung cancer undergoing autologous PBSCT in order to elucidate the role of IL-12 in immune response recovery following stem cell transplantation. RESULTS: Compared to IL-12 levels at 1 week after PBSCT for lung cancer patients, those at 3 weeks were significantly increased ( P<0.01). In contrast, serum IL-12 levels in malignant lymphoma patients did not change significantly. There were no significant differences in levels of other cytokines between 1 week and 3 weeks after transplantation in patients with lung cancer. The frequency of helper/inducer T cells was increased in peripheral blood 1 week after transplantation in both lung cancer and malignant lymphoma patients. There was a significant increase in activated T cell numbers following PBSCT. Furthermore, high levels of other activated T cells persisted in the post-PBSCT period in patients with lung cancer and the number of cytotoxic T cells significantly increased. Natural killer (NK) cell numbers also tended to increase, although that of malignant lymphoma was not significant. A strong correlation was observed between serum IL-12 levels and NK cell numbers and interferon-gamma levels in lung cancer not but in malignant lymphoma patients. The analysis of transfused PBSC showed that the numbers of granulocyte/macrophage colony-forming units were similar in lung cancer and malignant lymphoma patients. However, the number of CD34+ cells was significantly higher in lung cancer than in malignant lymphoma patients. All of the CD34+ subpopulations were lower in percentage in patients with lung cancer than in patients with malignant lymphoma. In particular, the CD34+ CD33- subpopulation was significantly lower in percentage in lung cancer patients. CONCLUSION: Our findings suggest that PBSC in lung cancer are potent mediators of anticancer activity and that they might play an immunotherapeutic role against autologous malignant cells. More... »

PAGES

29-36

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s004320100270

DOI

http://dx.doi.org/10.1007/s004320100270

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039399975

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11862469


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Etoposide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon-gamma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interleukin-12", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interleukins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Regression Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes, Cytotoxic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes, Helper-Inducer", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue and Organ Harvesting", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Autologous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Necrosis Factor-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vincristine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10\u201315 Fumizono-cho, Moriguchi Osaka 570, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshimura", 
        "givenName": "Chie", 
        "id": "sg:person.01311004421.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311004421.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10\u201315 Fumizono-cho, Moriguchi Osaka 570, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nomura", 
        "givenName": "Shosaku", 
        "id": "sg:person.0637542245.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637542245.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10\u201315 Fumizono-cho, Moriguchi Osaka 570, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kanazawa", 
        "givenName": "Shigenori", 
        "id": "sg:person.01340206206.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340206206.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10\u201315 Fumizono-cho, Moriguchi Osaka 570, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuwana", 
        "givenName": "Midori", 
        "id": "sg:person.0621306614.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621306614.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10\u201315 Fumizono-cho, Moriguchi Osaka 570, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamaguchi", 
        "givenName": "Kazuyuki", 
        "id": "sg:person.01062160226.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062160226.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10\u201315 Fumizono-cho, Moriguchi Osaka 570, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fukuhara", 
        "givenName": "Shirou", 
        "id": "sg:person.011002766332.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011002766332.56"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2002-01", 
    "datePublishedReg": "2002-01-01", 
    "description": "PURPOSE: High-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) has become an important treatment for solid tumors including lung cancer.\nMETHODS: We measured IL-12 levels in patients with lung cancer undergoing autologous PBSCT in order to elucidate the role of IL-12 in immune response recovery following stem cell transplantation.\nRESULTS: Compared to IL-12 levels at 1 week after PBSCT for lung cancer patients, those at 3 weeks were significantly increased ( P<0.01). In contrast, serum IL-12 levels in malignant lymphoma patients did not change significantly. There were no significant differences in levels of other cytokines between 1 week and 3 weeks after transplantation in patients with lung cancer. The frequency of helper/inducer T cells was increased in peripheral blood 1 week after transplantation in both lung cancer and malignant lymphoma patients. There was a significant increase in activated T cell numbers following PBSCT. Furthermore, high levels of other activated T cells persisted in the post-PBSCT period in patients with lung cancer and the number of cytotoxic T cells significantly increased. Natural killer (NK) cell numbers also tended to increase, although that of malignant lymphoma was not significant. A strong correlation was observed between serum IL-12 levels and NK cell numbers and interferon-gamma levels in lung cancer not but in malignant lymphoma patients. The analysis of transfused PBSC showed that the numbers of granulocyte/macrophage colony-forming units were similar in lung cancer and malignant lymphoma patients. However, the number of CD34+ cells was significantly higher in lung cancer than in malignant lymphoma patients. All of the CD34+ subpopulations were lower in percentage in patients with lung cancer than in patients with malignant lymphoma. In particular, the CD34+ CD33- subpopulation was significantly lower in percentage in lung cancer patients.\nCONCLUSION: Our findings suggest that PBSC in lung cancer are potent mediators of anticancer activity and that they might play an immunotherapeutic role against autologous malignant cells.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s004320100270", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "128"
      }
    ], 
    "name": "Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation", 
    "pagination": "29-36", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "bbaef17474e57bf10e8a4e7b738675fa0751f6ce44b5bd0fbf58714160e1e020"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11862469"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7902060"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s004320100270"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039399975"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s004320100270", 
      "https://app.dimensions.ai/details/publication/pub.1039399975"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T22:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000490.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s004320100270"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s004320100270'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s004320100270'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s004320100270'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s004320100270'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      20 PREDICATES      55 URIs      47 LITERALS      35 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s004320100270 schema:about N039661772f154fa4b6b21e4c12ae306a
2 N057cf003359247239a51ae112714baa7
3 N229c749a93d345648329f7dc96ac1910
4 N35d95af54a6f400686c2c6ce6de5d281
5 N40e05052edd84f45b5fd29b825ae1eb9
6 N4a631f4685e042f68587283acc3735a0
7 N53563d9f89cf40a699b40351ee1bb803
8 N655aa42ab20141c2bf0070a6934c29fd
9 N677bca653e9b401c978a0d00b1708e2f
10 N68d0ebed09d0420fa4bbd7180b92e8c0
11 N696b22800e1c429a8d10d1f86f892277
12 N6d3cd974a5814c9298e4d9456d30ae1c
13 N866108e8cb1c4199a3d9e1d79236618a
14 N98db83a89ad54a45881d9f37c9a79a2c
15 N9e59ea8f1dac4e5fb5d14723d8362557
16 Nc61ebed776b94a20ba69a80827ef75ca
17 Nc7388a4fb46e47378e5a739cee3b8486
18 Nc8735e329eba405884479c34d29b5cd6
19 Nd9718e0dc641465e95ff95342211c192
20 Nde92322bbe6f4655bd8a673a015e77ed
21 Ne14aa844da7f47a2a207ba32d202f9db
22 Nea9e471f7e164022a91673bcdef432e2
23 Nf6e3ab6c62a04bcf82b9d051142f257f
24 Nfaac533bcddf43fbb0675ff9cbce0763
25 Nfbb3274300c44d76a7e6b60abe3a8338
26 Nfd14aa500481401aa5c6515f33c5387b
27 anzsrc-for:11
28 anzsrc-for:1112
29 schema:author N20b90d24910849d78d56055ffc07647a
30 schema:datePublished 2002-01
31 schema:datePublishedReg 2002-01-01
32 schema:description PURPOSE: High-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) has become an important treatment for solid tumors including lung cancer. METHODS: We measured IL-12 levels in patients with lung cancer undergoing autologous PBSCT in order to elucidate the role of IL-12 in immune response recovery following stem cell transplantation. RESULTS: Compared to IL-12 levels at 1 week after PBSCT for lung cancer patients, those at 3 weeks were significantly increased ( P<0.01). In contrast, serum IL-12 levels in malignant lymphoma patients did not change significantly. There were no significant differences in levels of other cytokines between 1 week and 3 weeks after transplantation in patients with lung cancer. The frequency of helper/inducer T cells was increased in peripheral blood 1 week after transplantation in both lung cancer and malignant lymphoma patients. There was a significant increase in activated T cell numbers following PBSCT. Furthermore, high levels of other activated T cells persisted in the post-PBSCT period in patients with lung cancer and the number of cytotoxic T cells significantly increased. Natural killer (NK) cell numbers also tended to increase, although that of malignant lymphoma was not significant. A strong correlation was observed between serum IL-12 levels and NK cell numbers and interferon-gamma levels in lung cancer not but in malignant lymphoma patients. The analysis of transfused PBSC showed that the numbers of granulocyte/macrophage colony-forming units were similar in lung cancer and malignant lymphoma patients. However, the number of CD34+ cells was significantly higher in lung cancer than in malignant lymphoma patients. All of the CD34+ subpopulations were lower in percentage in patients with lung cancer than in patients with malignant lymphoma. In particular, the CD34+ CD33- subpopulation was significantly lower in percentage in lung cancer patients. CONCLUSION: Our findings suggest that PBSC in lung cancer are potent mediators of anticancer activity and that they might play an immunotherapeutic role against autologous malignant cells.
33 schema:genre research_article
34 schema:inLanguage en
35 schema:isAccessibleForFree false
36 schema:isPartOf N6afe29ff04c34a109b8a4bf4be52638d
37 Ne6c8c1a5ee734575a10cc632b7b7daa5
38 sg:journal.1313647
39 schema:name Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation
40 schema:pagination 29-36
41 schema:productId N357d7d57b6134a698c740ca0d24a589e
42 N3f5e074993504f4c90d0b8c91f0f89a3
43 N3fc6932062414b73a051981edf1bc715
44 N5d8fee09eb0e42c3a5d68b77ac13d010
45 N70e6bf159c14408a9e656db7cb73031f
46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039399975
47 https://doi.org/10.1007/s004320100270
48 schema:sdDatePublished 2019-04-10T22:27
49 schema:sdLicense https://scigraph.springernature.com/explorer/license/
50 schema:sdPublisher Nb16bb38b98b14462a6495df0e3255f82
51 schema:url http://link.springer.com/10.1007/s004320100270
52 sgo:license sg:explorer/license/
53 sgo:sdDataset articles
54 rdf:type schema:ScholarlyArticle
55 N039661772f154fa4b6b21e4c12ae306a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Tumor Necrosis Factor-alpha
57 rdf:type schema:DefinedTerm
58 N057cf003359247239a51ae112714baa7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Interleukins
60 rdf:type schema:DefinedTerm
61 N0eb615a87b3f4f748ae50df391d9a3bf rdf:first sg:person.0637542245.62
62 rdf:rest Nb053160e824a46c994c53da9e16973d8
63 N1f6155c04e2748879c9f489ebf588b2c rdf:first sg:person.011002766332.56
64 rdf:rest rdf:nil
65 N20b90d24910849d78d56055ffc07647a rdf:first sg:person.01311004421.55
66 rdf:rest N0eb615a87b3f4f748ae50df391d9a3bf
67 N229c749a93d345648329f7dc96ac1910 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Cyclophosphamide
69 rdf:type schema:DefinedTerm
70 N2c6f94764d07415a8af2aa8522069f8e rdf:first sg:person.0621306614.85
71 rdf:rest Ne147950d707c4fa394821711eef53b17
72 N357d7d57b6134a698c740ca0d24a589e schema:name pubmed_id
73 schema:value 11862469
74 rdf:type schema:PropertyValue
75 N35d95af54a6f400686c2c6ce6de5d281 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Lymphoma
77 rdf:type schema:DefinedTerm
78 N3f5e074993504f4c90d0b8c91f0f89a3 schema:name dimensions_id
79 schema:value pub.1039399975
80 rdf:type schema:PropertyValue
81 N3fc6932062414b73a051981edf1bc715 schema:name doi
82 schema:value 10.1007/s004320100270
83 rdf:type schema:PropertyValue
84 N40e05052edd84f45b5fd29b825ae1eb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Antineoplastic Combined Chemotherapy Protocols
86 rdf:type schema:DefinedTerm
87 N4a631f4685e042f68587283acc3735a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Female
89 rdf:type schema:DefinedTerm
90 N53563d9f89cf40a699b40351ee1bb803 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Interleukin-12
92 rdf:type schema:DefinedTerm
93 N5d8fee09eb0e42c3a5d68b77ac13d010 schema:name readcube_id
94 schema:value bbaef17474e57bf10e8a4e7b738675fa0751f6ce44b5bd0fbf58714160e1e020
95 rdf:type schema:PropertyValue
96 N655aa42ab20141c2bf0070a6934c29fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Male
98 rdf:type schema:DefinedTerm
99 N677bca653e9b401c978a0d00b1708e2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Etoposide
101 rdf:type schema:DefinedTerm
102 N68d0ebed09d0420fa4bbd7180b92e8c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Lung Neoplasms
104 rdf:type schema:DefinedTerm
105 N696b22800e1c429a8d10d1f86f892277 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Adult
107 rdf:type schema:DefinedTerm
108 N6afe29ff04c34a109b8a4bf4be52638d schema:issueNumber 1
109 rdf:type schema:PublicationIssue
110 N6d3cd974a5814c9298e4d9456d30ae1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Vincristine
112 rdf:type schema:DefinedTerm
113 N70e6bf159c14408a9e656db7cb73031f schema:name nlm_unique_id
114 schema:value 7902060
115 rdf:type schema:PropertyValue
116 N866108e8cb1c4199a3d9e1d79236618a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Transplantation, Autologous
118 rdf:type schema:DefinedTerm
119 N98db83a89ad54a45881d9f37c9a79a2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name T-Lymphocytes, Helper-Inducer
121 rdf:type schema:DefinedTerm
122 N9e59ea8f1dac4e5fb5d14723d8362557 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Tissue and Organ Harvesting
124 rdf:type schema:DefinedTerm
125 Nb053160e824a46c994c53da9e16973d8 rdf:first sg:person.01340206206.47
126 rdf:rest N2c6f94764d07415a8af2aa8522069f8e
127 Nb16bb38b98b14462a6495df0e3255f82 schema:name Springer Nature - SN SciGraph project
128 rdf:type schema:Organization
129 Nc61ebed776b94a20ba69a80827ef75ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name T-Lymphocytes
131 rdf:type schema:DefinedTerm
132 Nc7388a4fb46e47378e5a739cee3b8486 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Carcinoma, Non-Small-Cell Lung
134 rdf:type schema:DefinedTerm
135 Nc8735e329eba405884479c34d29b5cd6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Doxorubicin
137 rdf:type schema:DefinedTerm
138 Nd9718e0dc641465e95ff95342211c192 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Interferon-gamma
140 rdf:type schema:DefinedTerm
141 Nde92322bbe6f4655bd8a673a015e77ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Prednisone
143 rdf:type schema:DefinedTerm
144 Ne147950d707c4fa394821711eef53b17 rdf:first sg:person.01062160226.35
145 rdf:rest N1f6155c04e2748879c9f489ebf588b2c
146 Ne14aa844da7f47a2a207ba32d202f9db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Hematopoietic Stem Cell Transplantation
148 rdf:type schema:DefinedTerm
149 Ne6c8c1a5ee734575a10cc632b7b7daa5 schema:volumeNumber 128
150 rdf:type schema:PublicationVolume
151 Nea9e471f7e164022a91673bcdef432e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Regression Analysis
153 rdf:type schema:DefinedTerm
154 Nf6e3ab6c62a04bcf82b9d051142f257f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name T-Lymphocytes, Cytotoxic
156 rdf:type schema:DefinedTerm
157 Nfaac533bcddf43fbb0675ff9cbce0763 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Middle Aged
159 rdf:type schema:DefinedTerm
160 Nfbb3274300c44d76a7e6b60abe3a8338 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Humans
162 rdf:type schema:DefinedTerm
163 Nfd14aa500481401aa5c6515f33c5387b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Time Factors
165 rdf:type schema:DefinedTerm
166 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
167 schema:name Medical and Health Sciences
168 rdf:type schema:DefinedTerm
169 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
170 schema:name Oncology and Carcinogenesis
171 rdf:type schema:DefinedTerm
172 sg:journal.1313647 schema:issn 0171-5216
173 1432-1335
174 schema:name Journal of Cancer Research and Clinical Oncology
175 rdf:type schema:Periodical
176 sg:person.01062160226.35 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
177 schema:familyName Yamaguchi
178 schema:givenName Kazuyuki
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062160226.35
180 rdf:type schema:Person
181 sg:person.011002766332.56 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
182 schema:familyName Fukuhara
183 schema:givenName Shirou
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011002766332.56
185 rdf:type schema:Person
186 sg:person.01311004421.55 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
187 schema:familyName Yoshimura
188 schema:givenName Chie
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311004421.55
190 rdf:type schema:Person
191 sg:person.01340206206.47 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
192 schema:familyName Kanazawa
193 schema:givenName Shigenori
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340206206.47
195 rdf:type schema:Person
196 sg:person.0621306614.85 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
197 schema:familyName Kuwana
198 schema:givenName Midori
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621306614.85
200 rdf:type schema:Person
201 sg:person.0637542245.62 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
202 schema:familyName Nomura
203 schema:givenName Shosaku
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637542245.62
205 rdf:type schema:Person
206 https://www.grid.ac/institutes/grid.410783.9 schema:alternateName Kansai Medical University
207 schema:name The First Department of Internal Medicine, Kansai Medical University, 10–15 Fumizono-cho, Moriguchi Osaka 570, Japan
208 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...